Something was different about how representatives of the United States handled themselves at last month’s United Nations summit on drug policy, said Diederik Lohman, associate director of Health and Human Rights division at Human Rights Watch.
Instead of sitting up front during the UN General Assembly’s Special Session on Drugs, and corralling other countries into following its tougher than tough stance on drugs — which is what . . .
Want to read more? Please subscribe to The Crime Report!